Milestone Scientific Inc.
MLSS NYSE· Orthopedic, Prosthetic & Surgical Appliances & Supplies
Last close · Oct 27, 2026
$0.30
KIRA · Stoqly’s AI analyst, in plain words
- Milestone Scientific Inc. had $9.0M of revenue in fiscal 2025, up 4.0% on the year before. Over five years, revenue changed +10.5% a year on average.
- Its operating margin was −63.5%, up 14.8 pts: of every 100 in sales, about −63 is left after running the business.
- Milestone Scientific Inc. lost $5.7M in fiscal 2025.
- Free cash flow was −$2.9M in fiscal 2025, −32.7% of revenue.
Market cap
$27.9M
P/E
—
Revenue
$9.0M
Net income
−$5.7M
Free cash flow
−$2.9M
Operating margin
−63.5%
Milestone Scientific Inc. in 30 seconds · fiscal 2025
Are sales growing?
+4.0%
Only a little. Sales grew 4.0% last year.
Does it make a profit?
−63.8%
No. It lost money last year.
Does profit turn into cash?
−32.7%
No. It spent more cash than it brought in.
How healthy are the accounts?
2 / 8
Weak. It passes 2 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Milestone Scientific Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 31, 2026
- Legal name
- MILESTONE SCIENTIFIC INC.
- CIK
- 0000855683
Milestone Scientific Inc. · MLSS
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $10.3M | $8.8M | $9.8M | $8.6M | $9.0M |
| Revenue growth | 89.5% | −14.5% | 11.6% | −12.2% | 4.0% |
| Net interest income | −$0.0M | $0.1M | $0.1M | $0.1M | — |
| Gross margin | 61.3% | 55.7% | 69.1% | 74.6% | 71.4% |
| Operating margin | −71.6% | −100.2% | −72.3% | −78.3% | −63.5% |
| Net income | −$6.8M | −$8.7M | −$6.9M | −$4.7M | −$5.7M |
| Net margin | −66.2% | −98.9% | −70.5% | −54.6% | −63.8% |
| Diluted EPS | −$0.10 | — | — | −$0.06 | −$0.07 |
| Cash | |||||
| Cash from operations | −$4.0M | −$6.0M | −$5.3M | −$2.9M | −$2.9M |
| Capital expenditure | $0.0M | $0.0M | — | $0.0M | $0.0M |
| Free cash flow | −$4.0M | −$6.0M | — | −$2.9M | −$2.9M |
| FCF margin | −39.3% | −68.6% | — | −34.0% | −32.7% |
| Share count change | 9.1% | — | — | — | 2.8% |
| Debt and strength | |||||
| Cash and short-term investments | $29.6M | $17.4M | $6.0M | $3.3M | $1.1M |
| Shareholders' equity | $16.4M | $10.2M | $8.0M | $5.8M | $2.8M |
| Current ratio | 6.1x | 3.9x | 3.5x | 2.5x | 1.8x |
| Returns and quality | |||||
| Return on equity | −41.9% | −65.5% | −76.0% | −68.1% | −132.4% |
| Return on tangible equity | −42.4% | −87.1% | −88.5% | −82.9% | −209.3% |
| Piotroski F-score | 3 | 2 | 4 | 4 | 2 |
| Altman Z'' | −10.2 | −24.5 | −32.6 | −42.0 | −57.4 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Milestone Scientific Inc. · MLSS
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $0.30 a share, the company is worth $27.9M.
Source: SEC EDGAR XBRL filings (CIK 0000855683). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.